title: A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2.
authors.affiliation: Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Wagstaff
authors.forename: J B
authors.initials: JB
authors.lastname: Vermorken
authors.forename: G
authors.initials: G
authors.lastname: Schwartsmann
authors.forename: R J
authors.initials: RJ
authors.lastname: Scheper
authors.forename: C E
authors.initials: CE
authors.lastname: Hack
authors.forename: J H
authors.initials: JH
authors.lastname: Nuijens
authors.forename: A J
authors.initials: AJ
authors.lastname: Eerenberg-Belmer
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
mesh_terms: D000328:Adult; D000368:Aged; D003167:Complement Activation; D004341:Drug Evaluation; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology
chemical_list: D007376:Interleukin-2; D007371:Interferon-gamma